Form D · Pharmaceuticals

PARATEK PHARMACEUTICALS INC

Boston, MA · CIK 0001037643

Offering snapshot reported Jul 16, 2014 · SEC filing

Reported sold
$93M
Offering amount: $93M
Investors reported
54
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 30, 2014
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$46.5M$93MJul 15, 2014: $93,000,000.00Jul 15, 2014Jul 16, 2014: $93,000,000.00Jul 16, 2014

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 16, 2014Amendment$93,000,000$0vs Jul 15, 201454SEC filing
Jul 15, 2014Initial$93,000,000No comparison54SEC filing
Nov 5, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Mar 23, 2006PaperNot reportedNo comparisonNot reported

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$2.5M
Finders' fees
$0
Form D file number
021-221025
In addition, various noteholders converted promissory notes having an aggregate principal amount of $6,000,000 into shares of common stock.
Plus up to $75,000 in expense reimbursement.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Ladenburg Thalmann & Co. Inc.505
Trout Capital LLC131489

Source: Form D, filed Jul 16, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Beverly Armstrong Executive
Michael Bigham Director, Executive
Kathryn Boxmeyer Executive
Sean M. Johnston Executive
Richard Lim Director
Evan Loh Director, Executive
Dennis Molnar Executive
S. Ken Tanaka Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
75 Kneeland Street
Boston, MA, 02111